Cushman & Wakefield holder to sell 12,500 shares

Cushman & Wakefield Ltd. (CWK) received a notice that Nathaniel Robinson plans to sell up to 12,500 shares of common stock under Rule 144 through Fidelity Brokerage Services LLC on or after September 8, 2026.

Rhea-AI Filing Summary

Cushman & Wakefield Ltd. (CWK) received a notice that Nathaniel Robinson plans to sell up to 12,500 shares of common stock under Rule 144 through Fidelity Brokerage Services LLC on or after September 8, 2026. The shares relate to restricted stock vesting dated February 25, 2026.

The filing lists an aggregate market value of about $167,423.60 for the planned sale and reports 234,713,708 shares of common stock outstanding, which is a baseline figure, not the amount being sold.

Key Figures

Planned shares to be sold: 12,500 shares Aggregate market value: $167,423.60 Shares outstanding: 234,713,708 shares +2 more

5 metrics

Planned shares to be sold 12,500 shares Common stock under Rule 144 for the account of Nathaniel Robinson

Aggregate market value $167,423.60 Value of the 12,500 CWK common shares covered by the Form 144

Shares outstanding 234,713,708 shares Cushman & Wakefield common stock outstanding as reported in the notice

Planned sale date September 8, 2026 Date listed with the NYSE sale of 12,500 common shares

Restricted stock vesting date February 25, 2026 Date of restricted stock vesting for the common shares to be sold

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 02/25/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Nathaniel Robinson"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale was disclosed for CWK in this Form 144?

The notice states that Nathaniel Robinson plans to sell up to 12,500 shares of Cushman & Wakefield Ltd. common stock under Rule 144 through Fidelity Brokerage Services LLC.

What is the approximate value of the CWK shares covered by this Form 144?

The filing lists an aggregate market value of about $167,423.60 for the planned sale of 12,500 common shares of Cushman & Wakefield Ltd.

When are the CWK securities expected to be sold under this Form 144?

The Form 144 identifies September 8, 2026 in the securities information section in connection with the planned sale of 12,500 CWK common shares on the NYSE.

How many Cushman & Wakefield (CWK) shares are outstanding according to this notice?

The notice reports that 234,713,708 shares of Cushman & Wakefield Ltd. common stock were outstanding, serving as context for the planned sale of 12,500 shares.

What is the origin of the CWK shares to be sold under this Form 144?

The filing describes the securities to be sold as Common stock acquired through Restricted Stock Vesting on February 25, 2026, with the transaction type listed as Compensation.

Who is executing the planned CWK share sale disclosed in this Form 144?

The broker listed is Fidelity Brokerage Services LLC, and the Form 144 is signed by Wade Moss as a duly authorized representative of Fidelity, acting as attorney-in-fact for Nathaniel Robinson.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 02:42 PM EDT Accepted by SEC EDGAR 09/08/2026 - 02:41 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001747604
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cushman & Wakefield Ltd.
SEC File Number	001-38611
Address of Issuer	CLARENDON HOUSE, 2 CHURCH STREET HAMILTON BERMUDA HM 11
Phone	441 298 3300
Name of Person for Whose Account the Securities are To Be Sold	Robinson Nathaniel
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12500	167423.60	234713708	09/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/25/2026	Restricted Stock Vesting	Issuer			12500	02/25/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Nathaniel Robinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)